Skip to main content

Effect of carryover of clot activators on coagulation tests during phlebotomy.

Fukugawa Y, Ohnishi H, Ishii T, Tanouchi A, Sano J, Miyawaki H, Kishino T, Ohtsuka K, Yoshino H, Watanabe T

Publication: Am J Clin Pathol (2012) • Vol 137 • Page 900-3PMID: 22586048View on PubMed

Purpose

The purpose of this paper was to determine the effects of clot activators on coagulation testing.

Conclusion

The addition of clot activators in vitro to specimens intended for coagulation testing resulted in minimal but significant changes in prothrombin time (PT) and activated partial thromboplastin time (aPTT). On the other hand, fibrin monomer complex (FMC) was significantly and remarkably affected by the addition of clot activator fluid containing thrombin. In specimens from healthy individuals and patients on warfarin, PT was minimally but significantly affected by tube draw order when coagulation tubes were drawn before and after serum tubes containing clot activator. Fibrinogen was also affected by tube draw order, but only for specimens from patients on warfarin. Other coagulation parameters were not affected by tube draw order.

Studies (2)

Purpose

The purpose of this study was to determine the effects of the addition of clot activator fluid to blood specimens in vitro on PT, aPTT, fibrinogen, D-dimer, and FMC measurements. Specimens were collected in sodium citrate Venoject II tubes, and clot activator fluid was added which had been prepared by adding saline to Venoject II tubes containing either thrombin and glass particles or only glass particles, or by adding saline to Vacutainer tubes containing silica particles. Coagulation testing was performed immediately after centrifugation.

Summary of Findings

PT was significantly increased by the addition of any amount of clot activator fluid containing thrombin, glass particles, or silica particles, but all values were within 3% of the controls (saline added). aPTT was significantly decreased and FMC was significantly increased by the addition of thrombin clot activator fluid, and the changes were proportional to the amount of fluid added. The effects of glass and silica particle clot activator fluid on aPTT and FMC were minimal. Fibrinogen and D-dimer were generally not affected by the addition of any clot activator fluid, although some random significant changes were observed.
  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
  • Platforms

    MorphologyHematology/ auto analyzer
    GlycoproteinHematology/ auto analyzer
    PeptideHematology/ auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBiospecimen components
    10 uL clot activator fluid
    10 uL saline
    2 uL clot activator fluid
    2 uL saline
    5 uL clot activator fluid
    5 uL saline
    Glass particles
    Silica particles
    Thrombin and glass particles